نتائج البحث

...[[Galectin]] - [[Myelin-associated glycoprotein]] - [[N-Acetylglucosamine receptor]] - [[Selectin]] - [[Sialoadhesin]] ...eptor]] - [[CD94]] - [[Collectin]] ([[Mannan-binding lectin]]) - [[Mannose receptor]] - [[Versican]]

...' ([[Ceruloplasmin]]) - ''iron'' ([[Iron-binding proteins]], [[Transferrin receptor]])

| group7 = [[Vasopressin receptor antagonist]]s<br />([[distal convoluted tubule|DCT]] and [[collecting duct| | list7 = ''[[Vasopressin receptor antagonist#Vaptans|vaptans]]:'' [[Conivaptan]] * [[Mozavaptan]] * [[Satavap

| group1 = [[beta2-adrenergic receptor agonist|β₂-agonists]]

|group2 = [[Receptor (biochemistry)|Receptor]] [[agonist]]s<BR>and [[Receptor antagonist|antagonist]]s | group5 = [[adenosine A1 receptor|A1 agonist]]

|group2 = [[Endothelin receptor antagonist]]s

* ''[[Cannabinoid receptor type 1|CB1]]'' ([[Surinabant]]) * ''[[Metabotropic glutamate receptor|mGluR]]'' ([[Acamprosate]])

** ترتبط [[مستقبلات تحولية|المستقبلات التحولية]] Metabotropic receptor مع [[برة تين ج|برتينات ج]] وتؤثر على الخية ب

| group1 = [[GABAA receptor|GABA_A receptor]] agonist |group3 = [[AMPA receptor]]

| group2 = [[P2Y12|ADP receptor/P2Y₁₂]] [[Adenosine diphosphate receptor inhibitor|inhibitors]] * ''[[Thromboxane receptor antagonist|receptor antagonist]]''

| group1 = [[GABAA receptor|GABA_AR]] [[Positive allosteric modulator|PAMs]]

| group1 = {{abbrlink|TRPs|Transient receptor potential channels}} * See [[Template:Transient receptor potential channel modulators|here]] instead.

* ''[[thrombopoietin receptor agonist]]'' ([[Romiplostim]]

| group2 = [[Serotonin receptor agonist|5-HT₁ agonists]]

| group1 = [[GABAA receptor|GABA_A]] | group2 = [[GABAB receptor|GABA_B]]

...| last2 = Douglas | first2 = S. D. | title = Substance P and neurokinin-1 receptor modulation of HIV | journal = Journal of Neuroimmunology | volume = 157 | i ...ournal | last = Saria | first = A. | title = The Tachykinin NK₁ receptor in the brain: pharmacology and putative functions | journal = European Jour

...في سن 65 أو بعده، ظهرت معدلات مستقبل الاستروجين النوعية selective estrogen receptor modulators (SERMS) كأداة جديدة هامة في أبحاث علاج

* هناك بعض الأدلة على أن مضادات الأنجيوتنسين الثاني (angiotensin || receptor antagonist) (غالبا (اللوسارتان losartan)يقلل من شدة

...للكورتيزول بتحفيز مستقبل القِشْرانِيَّاتُ المَعْدِنِيَّة(Mineralocorticoid receptor) والذي سيؤدّي إلى تأثيرات مشابهة لفَرْطُ

...ة داخل خلوية (intracellular vesicle) . يحدث الالتقام المتواسط بالمستقبلات (Receptor-mediated endocytosis)عندما ترتبط الركيزة بمستقبل غ